Abstract
Objective
Examination of intervertebral disc (IVD) regeneration in an ovine annular lesion model.
Hypothesis
Sulfation motifs are important functional determinants in glycosaminoglycans (GAGs). Previous studies have correlated 3-B-3(−) and 7-D-4 chondroitin sulfate (CS) motifs in tissues undergoing morphogenetic transition in development. We hypothesize that these motifs may also be expressed in degenerate IVDs and may represent a reparative response.
Design
Induction of disc degeneration by 5 mm or 6 × 20 mm lesions in the annulus fibrosus (AF) over 6 or 3 to 6 months postoperation (PO). Tissue sections were stained with toluidine blue–fast green, 3-B-3(−) and 7-D-4 CS-sulfation motifs were immunolocalized in 3-month PO 6 × 20 mm lesion IVDs. Sulfated glycosaminoglycan (GAG), 3-B-3(−), and 7-D-4 epitopes were quantitated by ELISIA (enzyme-linked immunosorbent inhibition assay) in extracts of AF (lesion site and contralateral half) and nucleus pulposus (NP) 0, 3, and 6 months PO.
Results
Collagenous overgrowth of lesions occurred in the outer AF. Chondroid metaplasia in ~20% of the 6 × 20 mm affected discs resulted in integration of an outgrowth of NP tissue with the inner AF lamellae preventing propagation of the lesion. 3-B-3(−) and 7-D-4 CS sulfation motifs were immunolocalized in this chondroid tissue. ELISIA quantified CS sulfation motifs demonstrating an increase 3 to 6 months PO in the AF lesion and a reduction in sulfated GAG not evident in the contralateral AF.
Conclusions
(1) Outer annular lesions underwent spontaneous repair. (2) Chondroid metaplasia of the inner 6 × 20 mm defect prevented its propagation suggesting an apparent reparative response.
Keywords: chondroitin sulfate motifs, tissue remodeling, tissue regeneration, 3-B-3(−), 7-D-4, annular repair
Introduction
Low back pain (LBP) is a leading global musculoskeletal condition and a major public health concern with approximately 650 million people affected.1 The global socioeconomic impact of LBP is increasing with changing trends in aging population demographics.1-3 United Nations World Ageing Data collected from 195 countries evaluated by the World Bank shows that the number of individuals aged ≥65 years will dramatically increase over the next 2 decades.4 LBP is associated with degenerative disc disease (DDD)5 and is a major global cause of disability1 imposing a heavy burden on health care systems and significant direct and indirect socioeconomic impact6 accounting for total annual health care expenditure of £11 billion in the United Kingdom in 2000,7,8], $9.17 billion in Australia in 2003,9 and $50 to $90 billion annually in the United States.10-12 The World Health Organization (WHO) IRIS Low Back Pain Initiative stated that studies on IVD regeneration are a high priority research area,13 LBP was made a national health care priority in Australia in 2009.14 LBP treatment with opioid pain killing prescriptions in the United States is currently running at epidemic proportions.15
Regeneration of the intervertebral disc (IVD) is limited by a low cell density and poor nutrient supply,16,17 there is a tremendous unmet need for the development of an effective treatment for intervertebral disc degeneration (IVDD) and associated LBP.18,19 The ovine model was developed to evaluate aspects of IVDD but was also useful in studies on disc regeneration and prospective treatments to either slow or prevent DDD or stimulate IVD regeneration.20-22 The ovine model of 199023,24 used a controlled 5-mm deep annular lesion, which produced IVDD over an 18-month period and was characterized using biochemical,25 histochemical, Western blotting of aggrecan catabolism,26,27 and biomechanical evaluation.28-32 A steady decline in IVD proteoglycan/catabolism of aggrecan were major features,26,33 upregulation in decorin and biglycan biosynthesis, fragmentation of fibromodulin and biglycan was also observed27,34 with roles in collagen fibrillogenesis, matrix assembly, and signal transduction important in IVD regeneration.35-41 An influx of transforming growth factor–β (TGF-β) expressing cells42 and in-growth of blood vessels43 promoted lesion repair.43-45 A focal reduction in vertebral subchondral bone density, endplate vascularity,46 remodeling of vertebral bone,47 facet joint degeneration were also observed48 and disruption of normal annular laminate structure, attachment to vertebral bone and internal nucleus pulposus (NP) organization.31,49,50 A modification of this model was developed in 2012 using a 6 × 20 mm annular lesion,51 biochemical, compositional, gene profiling, and histopathological scoring confirmed its degenerative features.22 Exogenously administered mesenchymal stem cells (MSCs) promoted repair of the annular lesion. Hyaluronan (HA) oligosaccharides generated by depolymerization of HA during IVDD promoted extracellular matrix (ECM) remodeling through matrix metalloproteinases (MMPs) and spontaneous repair of the outer annular defect. Spinal manipulation studies demonstrated annular lesions perturbed normal spinal biomechanics, neurophysiology, stabilization of vertebral lumbar motion segments, and dynamic dorsoventral lumbar spinal stiffness.52-55 Inflammatory cytokine-mediated multifidus remodeling may indirectly contribute to the generation of LBP.56-59
The aim of the present study was to use the ovine model51 to examine changes in chondroitin sulfate (CS) sulfation associated with IVD repair. Monoclonal antibodies (MAbs) to the CS sulfation motifs, 3-B-3(−) and 7-D-4 have immunolocalized these epitopes in tissue development and pathological remodeling60 in the bursae of Fabricius,61 skin,62 neural tissues,63 articular cartilage,64-67 embryonic chick bone marrow, and epiphyseal cartilage.63 CS-epitope mapping of proteoglycans in health and disease60,68-71 showed 3-B-3(−) and 7-D-4 associated with progenitor/stem cell proteoglycans in fetal rat IVD, human knee and elbow, and discrete progenitor/stem cell niches. Cell clusters displayed 7-D-4 and 3-B-3(−) in fibrillated adult OA articular cartilage and in annular remodeling.72,73 A positive correlation in 3-B-3(−) and 7-D-4 levels in areas of ECM remodeling is evidence of how the glycosaminoglycan (GAG) chain proteoglycan structure is dynamically modulated during pathological remodeling/repair, recapitulating changes seen in foetal skeletal development.60,74
Materials and Methods
Materials
All material and supplier details were as indicated earlier.74
Animal Welfare and Ethics
A total of fifty 2- to 3-year-old merino wethers (castrated males) were purchased from local sale yards and held in open paddocks till required. All animal welfare and ethics for this work were approved by the University of Sydney Animal Care and Ethics Committee under ethics approval A45/6-2011/3/5544.
Antibodies
MAb 3-B-3 and 7-D-4 were kind gifts of Prof. B. Caterson, School of Biosciences, University of Cardiff, UK. Chondroitinase ABC-digested rat chondrosarcoma proteoglycan was used as antigen to raise MAb 3-B-3.75 Antibody 7-D-4 was produced from 17-day embryonic chick bone marrow proteoglycan as antigen.76
Methods
Animal Model Procedures
A total of 48 animals were used in this study, and these were separated into 3 groups. Group A (n = 12) was divided into 6 animals that received 5-mm annular lesions at L1-L2, L3-L4, L5-L6 and 6 nonoperated control (NOC) animals. These were sacrificed 6 months postoperation (PO). Group B (n = 24) were divided unto a lesion group (n = 12), which received 6 × 20 mm lesions at L1-L2, L3-L4, L5-L6, and NOC sheep (n = 12), 6 animals were sacrificed at 3 months PO and the remainder at 6 months PO in each group. Group C consisted of 18 animals, which received 6 × 20-mm lesions at L1-L2, L3-L4, L5-L6, 6 animals were sacrificed at 0, 3, and 6 months PO in this group, an additional 6 NOC animals were sacrificed at 6 months PO. IVDs from group A and B sheep were examined histologically. Group C IVDs were dissected into annulus fibrosus zone 1 (AF1), AF2, and NP and the tissue extracts analyzed by ELISIA (enzyme-linked immunosorbent assay) and their sulfated GAG contents determined. Thus, a total of 144 IVDs were analyzed in this study. These time points were selected based on earlier studies which demonstrated at the selected time points early stages of disc degeneration was evident. Six animals per time point containing 18 treated IVDs previously provided statistically significant data.
Zonal Dissection of IVDs and Extraction of Proteoglycans for Compositional and ELISIA Analysis of 3-B-3(−) and 7-D-4 CS Sulfation Motifs
These IVDs were horizontally bisected and photographed, then zonally dissected into the AF half containing the lesion site (AF zone 1), unaffected contralateral AF zone 2 and the central NP tissue zone. AF zone 1, AF zone 2, and NP were weighed, finely diced, and extracted with 4 M GuHCl containing protease inhibitors (10 mL/g tissue) for 48 hours and the extract clarified by centrifugation then dialyzed against MilliQ distilled water to remove GuHCl and freeze dried, redissolved in MilliQ distilled water and their sulfated GAG contents determined by reaction with the metachromatic dye 1, 9-dimethylmethylene blue. Their 3-B-3(−) and 7-D-4 CS sulfation epitopes were quantitated by ELISIA.
Native Composite Agarose–Polyacrylamide Gel Electrophoresis (CAPAGE) and Immunoblotting of IVD Extracts
Aliquots of IVD or shark cartilage extracts (5µg sulfated GAG/10 µL per well) were electrophoresed in 3-mm thick CAPAGE slab gels77 and the gel stained directly with toluidine blue to visualize proteoglycans or electroblotted to nitrocellulose membranes by semidry blotting using 1/50 dilutions of 7-D-4 or 3-B-3 hybridoma conditioned media samples in 50 mM Tris-HCl, 0.1 M NaCl, pH 7.2 at 4°C, primary antibodies were localized using alkaline phosphatase conjugated goat anti-mouse IgM secondary antibodies (1/1000 dilution, 1 hour at room temp) and visualized using NBT/BCIP (nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate) substrates in 0.1 M Tris-HCl pH 9.2.
Histological Processing of IVDs
IVD spinal motion segments were trimmed of excess bone leaving a portion of the inferior and superior vertebral body attached to the IVD and fixed en bloc for 48 hours in 10% neutral buffered formalin, then decalcified in 10% (v/v) formic acid 5% (v/v) neutral buffered formalin for 10 to 12 days using frequent changes of decalcification solution and constant agitation till a needle could be inserted into the vertebral body with moderate pressure. The fixed decalcified IVD specimens were then cut into 5-mm slabs encompassing the lesion site and dehydrated in graded ethanol washes and xylene, and embedded in paraffin wax. Vertical microtome sections through the IVD and superior and inferior vertebral bodies were subsequently cut at 4 µm thickness and attached to SuperFrost Plus glass microscope slides (Menzel-Glaser, Germany) by baking at 55°C for 30 minutes in an oven and stored at room temperature overnight before use.
Immunolocalization of the 3-B-3(−) and 7-D-4 CS Sulfation Motifs
Vertical tissue sections through IVD lesion sites and inferior and superior vertebral bodies were deparaffinized in xylene and in a sequential series of ethanol solutions to water. Antigen retrieval was carried out with proteinase K digestion (20 µg/mL in Tris-EDTA buffer) for 10 minutes at 37°C and endogenous peroxidase activity blocked 3% H2O2 for 5 minutes. The slides were then washed with 50 mM Tris 150 mM NaCl, 0.05% (w/v) Tween-20 pH 7.2 (TBST) and blocked in 1% bovine serum albumin (BSA) in TBST. The slides were then incubated with primary antibody hybridoma conditioned media, clone 3-B-3 (1:500) or clone 7-D-4 (1:1000) diluted in 1% BSA in TBST for 16 hours at 4°C, washed twice with TBST before incubation with biotinylated anti-mouse IgG secondary antibodies (1:500; GE Healthcare) for 1 hour at room temperature. The slides were then washed twice with TBST, and streptavidin–horse radish peroxidase (HRP) (1:250; GE Healthcare) added for 1 hour at room temperature. Following further washes in TBST, NovaRED chromogen (Vector Laboratories; Burlingame, CA) was used for color development in HRP development buffer. The slides were then counterstained with hematoxylin (Gill’s #3, Vector Laboratories) for 6 seconds and rinsed in deionized water, then dehydrated through a graded ethanol series, mounted in Eukitt and imaged using a Mirax Digital Slide Scanner (Zeiss). Negative control slides were similarly processed using irrelevant isotype matched mouse Ig whole antibodies (2 μg/mL; Invitrogen, Carlsbad, CA) or with omission of primary antibodies. Both sets of controls were negative.
Toluidine Blue Staining
Glycosaminoglycans were stained in IVD sections for 10 minutes with 0.04% (w/v) toluidine blue in 0.1 M sodium acetate buffer, pH 4.0, followed by a 2-minute counterstain in 0.1% (w/v) fast green FCF.
Hematoxylin and Eosin Staining
IVD sections were stained in Mayers hematoxylin (5 minutes) to assess cellular morphology, rinsed in tap water blued in Scotts Blueing solution (1 minute) and counterstained in 0.0001% eosin (5 minutes), dehydrated in 95% (v/v) ethanol then absolute ethanol, cleared in xylene and mounted.
Sulfated GAG Analysis of IVD Tissue Extracts
The proteoglycan content of tissue extracts and proteoglycan standards were measured by their sulphated GAG contents by reaction with the metachromatic dye 1,9-dimethyl methylene blue using bovine tracheal CS as standard.78
Isolation and Characterization of 7-D-4 and 3-B-3(−) Proteoglycan Standards
7-D-4 Standard
Shark cartilage purchased from a local Chinese traditional medicinal apothecary was rehydrated overnight in isotonic saline and finely diced and extracted in 10 volumes buffered 4 M GuHCl pH 5.8 + protease inhibitors with end-over-end stirring for 48 hours at 4°C. The tissue extract was clarified by centrifugation and CsCl added to a starting density of 1.4 g/mL and dissociative isopycnic density gradient ultracentrifugation conducted at 200,000 × g in a Sorval OTD75B vertical rotor for 48 hours. The tubes were manually fractionated into 9 equal fractions. Known volumes of fractions were weighed to construct a density gradient profile and aliquots were reacted with 1,9-dimethyl methylene blue to determine proteoglycan distribution. The densest fraction was used as a source of purified 7-D-4 standard.
3-B-3(−) Standard
Lumbar IVDs from 3 stillborn lambs were finely diced and extracted as outlined for preparation of the 7-D-4 shark cartilage standard and subjected to dissociative CsCl density gradient ultracentrifugation as outlined for the 7-D-4 standard except the D1 fraction was subjected to a second ultracentrifugation and the D1D1 fraction used as 3-B-3(−) standard.
Quantitation of the 7-D-4 and 3-B-3(−) Sulfation Motifs by ELISIA
Binding curves were made for the 7-D-4 and 3-B-3(−) standards to the Maxisorp microtiter plates to determine optimal standard proteoglycan coating concentrations for the ELISIA. The standards were redissolved in 50 mM Tris-HCl pH 7.2 containing 100 mM NaCl (TBS) containing 2% w/v BSA at 100 µg/mL and a series of serial doubling dilutions were prepared. Sextuplet replicates (50 µL) were applied to 96-well microtiter plates and binding undertaken at 4°C overnight, the well contents were then flicked out and the wells rinsed three times with TBS. Binding curves of proteoglycan standards were determined using 1,9-dimethyl methylene blue.78 Plates were subsequently coated using a 50 µg/mL standard solution. A series of serial doubling dilutions of disc proteoglycan samples with 1/50 dilutions of MAb 7-D-4 and 3-B-3 hybridoma conditioned media samples in TBS were prepared and thoroughly mixed. After 1 hour at 37°C, aliquots (50 µL) of the serial dilutions were added to the coated plates and the plates incubated for 3 hours at 37°C. The plate contents were then flicked out and 200 µL of a 2% BSA in TBS blocking solution added. After 1 hour at 37°C the wells were emptied and washed 3 times with TBS then alkaline phosphatase conjugated anti mouse IgM secondary antibody was added for 1 hour at 37°C. The wells were rinsed again in TBS and ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) in development buffer (200 µL) was added. Color development was allowed to proceed for up to 1 hour at 37°C. The plates were read at 450 nm using a plate reader. ELISIAs were determined using 6 replicates and mean ± SD data used to plot ELISIA curves. 7-D-4 and 3-B-3(−) epitope levels were determined from the 50% inhibition values.79
Statistical Methods
Spatiotemporal distributions of sulphated GAG and 3-B-3(−) and 7-D-4 CS sulfation motif ELISIA data in nonoperated control and lesion affected IVD tissue zones were compared using analysis of variance. Nonnormally distributed data were analyzed using Kruskal-Wallis 1-way analysis of variance. Significant differences in data sets were evaluated using the Mann-Whitney U test using GraphPad Prism software, the alpha level was set at 0.05.
Results
Frozen spinal segments were sectioned through the annular lesion site using a sledge microtome and the cut surfaces photographed ( Fig. 1 ). This demonstrated thickening of the outer annular lamella and macroscopic repair while the surgical incision in the inner AF defect was still clearly visible ( Fig. 1a ). Macroscopic views of bisected IVDs that had received 6 × 20 mm lesions showed the lesion confined to the outer third of the AF 3 months postoperatively ( Fig. 2a ) while at 6 months PO, blood vessels had penetrated deeper into the IVD and some discoloration of the NP was also evident ( Fig. 2b ). Localized thickening of annular lamellae spanning the original defect site was also a prominent feature of the 6-month PO defect IVDs ( Fig. 2b ). Comparison with age-matched NOC IVDs showed clear differences between the macroscopic appearances of NOC and 3- and 6-month lesion IVDs ( Fig. 2a-c ). Discs from the group C sheep were dissected into AF1, AF2, and NP tissue zones as shown ( Fig. 2d ) and proteoglycans were extracted from these tissue zones for compositional and ELISIA assays. Toluidine blue–fast green histology of NOC IVDs from group A and B sheep showed a widespread and uniform GAG distribution through the IVD except in the outer AF, which had markedly lower GAG levels ( Fig. 2e ). Comparison of the NOC IVD with a 6 × 20 mm lesion IVD showed a decreased disc height consistent with its lower GAG levels stained with toluidine blue, focal reduction in GAG levels in the outer AF lesion zone and propagation of the annular lesion through the IVD, clear evidence of the disc degeneration previously demonstrated in earlier studies using this type of annular lesion ( Fig. 2f ).
Figure 1.

Depiction of a 5-mm deep controlled outer annular lesion in an ovine lumbar intervertebral disc (IVD) showing spontaneous repair in the outer annulus fibrosus (AF; small black arrow) and thickened annular lamellae 6 months after making the lesion, inner regions of the lesion remain unhealed. Macroscopic image of a nonfixed vertical sagittal section depicting the ovine IVD and adjacent superior and inferior vertebral bodies (a). The resultant IVD degeneration induced by the annular lesion results in proteoglycan depletion from the nucleus pulposus (NP), which is dehydrated and more fibrous due to collagen deposition and posterior annular lamellae are inverted, a reduced disc height is also evident and the normal organization of the NP is disrupted. A nonoperated control intervertebral disc is also shown (b) with anatomic features numbered. 1, outer AF; 2, inner AF; 3, NP; 4, cranial cartilage end-plate (CEP); 5, caudal CEP; 5a, edge of ring apophysis; 6, caudal vertebral body; 7, caudal vertebral body; 8, posterior AF; 9, spinal canal. A control nonoperated ovine lumbar IVD is also shown (b) where the outer lamellar layers are clearly evident. The high proteoglycan content of the NP results in bulging of this tissue region out of the cut surface of the tissue section and the IVD has a normal disc height. There is little discoloration of disc tissue in this IVD compared to the lesion affected IVD.
Figure 2.
Morphological appearance of horizontally bisected 3- and 6-month postoperation (PO) 6 × 20 mm lesion affected (a, b) and control (c) sheep intervertebral discs (IVDs) depicting the left anterolateral annular defect (red arrow), which is also shown diagrammatically (d). This diagram also depicts the zonal dissection undertaken on a lesion disc for subsequent ELISIA (enzyme-linked immunosorbent inhibition assays) analyses. At 3 months, the defect is confined to the outer annulus fibrosus (AF) (a) while at 6 months some spontaneous repair of the outer lesion is evident (b) while the inner margins of the lesion are unhealed and are delineated by prominent blood vessel penetration, discoloration of the nucleus pulposus (NP) is also a prominent feature. Small clones of cells were observed in areas of annular repair tissue in the boxed area depicted in (f) in a lesion-affected disc which has propagated through the inner AF. A nonoperated control disc is shown for comparison in (e) (For interpretation of the references to colours in this figure legend, refer to the online version of this article).
Higher magnification views of an area equivalent to the boxed area in Figure 2f showed small groups of cells associated with the 5-mm lesion depicted in Figure 1 and focal loss of GAG ( Fig. 3a ). Small clones of cells were also evident in the boxed region of Figure 2f in the 6 × 20 mm lesion IVDs as well as a reduction in GAG staining ( Fig. 3b ). The cellular morphology of the inner ( Fig. 4a ) and outer AF ( Fig. 4b ) of NOC IVDs did not resemble that of the lesion IVDs ( Fig. 5a and b ) although occasional cell doublets were seen ( Fig. 4a ) but no evidence of small groups of cells.
Figure 3.

Toluidine blue histology of intervertebral disc (IVD) tissue sections depicting cell clustering and proteoglycan localization in ovine IVDs subjected to a 5-mm anterolateral annular lesion with degeneration induced for 6 months (a) and in a 6 × 20 mm lesion affected IVD in which disc degeneration was allowed to proceed for 3 months postoperation.
Figure 4.

Medium power magnification images depicting the glycosaminoglycan (GAG) distribution and cellular morphology in the inner annulus fibrosus (AF) (a) and outer AF (b) of a nonoperated control intervertebral disc (IVD) specimen stained with toluidine blue-fast green. Outer AF cells have an elongated fibroblastic morphology while inner AF cells have a plumper more rounded morphology (For interpretation of the references to colours in this figure legend, refer to the online version of this article).
Figure 5.

High power magnification images depicting the glycosaminoglycan (GAG) distribution and cellular morphology in the inner annulus fibrosus (AF) (a) and outer AF (b) of a nonoperated control intervertebral disc (IVD) specimen. Disc cells occur mainly as single cells surrounded by extensive extracellular matrix. Occasional doublet cells are observed in the inner AF (a) but no clones of cells as depicted in the annular repair tissue in Figure 3 . Alternate lamellar layers in the outer AF are also evident.
The 7-D-4 and 3-B-3(−) CS sulfation motifs were abundantly expressed in the NP of NOC IVDs but sparsely in the AF ( Figs. 6a and 7a ). In 6 × 20 mm lesion IVDs, an outgrowth of the NP along the line of the annular lesion contained abundant levels of these CS motifs ( Figs. 6c and 7c ). Higher magnification examination of these NP outgrowth tissues identified small groups of chondroid cells containing well-defined pericellular matrices rich in the 7-D-4 and 3-B-3(−) epitopes ( Figs. 6d , e and 7d , e ). These cells were contained in distinct nests in a matrix rich in the 7-D-4 and 3-B-3(−) epitopes ( Figs. 6e and 7e ). These chondroid cells were considerably larger than the AF or NP cells and of a dissimilar morphology and were only observed in the 6 × 20 mm lesion IVDs and not the 5-mm lesion IVDs. Examination of the 6 × 20-mm lesion IVD tissue sections stained with toluidine blue–fast green showed 11/36 IVDs displayed these NP outgrowths rich in GAG ( Fig. 8a-i ). These were prominent 3 months after making the annular lesion ( Fig. 8d-g ) but by 6 months PO, they had resorbed to a significant extent ( Fig 8a-c ). Higher power examination of this chondroid tissue demonstrated its integration with the lamellar layers of the inner AF apparently representing a repair response to the annular lesion ( Fig. 8i ). In disc specimens that displayed chondroid metaplasia, the annular lesion failed to propagate further into the IVD.
Figure 6.
Immunolocalization of the 7-D-4 CS sulfation motif throughout the nucleus pulposus (NP) and inner annulus fibrosus (AF) to a lesser extent (a-d) in the nonoperated control (NOC) (a, b) and lesion intervertebral discs (IVDs) (c, d). The boxed areas in (a) and (c) are depicted at higher magnification in (b, d) while an area of the lesion is depicted at higher magnification in (e). The outer annulus fibrosus (OAF) and NP is also labeled in the lower power images. Rounded groups of cells with prominent 7-D-4-+ve basophilic moats were evident adjacent to annular lesions (arrowed) (d, e). These cells occurred in small groups and were larger than normal disc fibrochondrocytes (e).
Figure 7.
Strong expression of 3-B-3(−) CS sulfation epitope throughout the nucleus pulposus (NP) and inner annulus fibrosus (AF) to a lesser extent (a-d) in the non-operated control (NOC) (a, b) and lesion intervertebral discs (IVDs) (c, d). The boxed areas in (a) and (c) are depicted at higher magnification in (b, d) while an area of the lesion is depicted at higher magnification in (e). The outer annulus fibrosus (OAF) and NP is also labeled in the lower power images. Rounded groups of cells surrounded by prominent 3-B-3(−)+ve basophilic moats were evident adjacent to annular lesions (d, e). These cells occurred in small groups and were larger than normal disc fibrochondrocytes (e).
Figure 8.
Toluidine blue–fast green stained tissue sections through annular repair regions depicting cartilaginous tissue that had been laid down in the lesion site through chondroid metaplasia. The images show examples of different stages of the resorption of the chondroid tissue mass 6 months postinduction of disc degeneration (a, b, c) through to formation of chondroid tissue 3 months postinduction of disc degeneration (d, e, f, g). A nonoperated disc is also shown (h). A higher magnification image shows the integration of the chondroid metaplastic tissue with the annular lamellae (i). Scale bar = 100 µm (For interpretation of the references to colours in this figure legend, refer to the online version of this article).
To further investigate the 7-D-4 and 3-B-3(−) epitopes in the ovine IVD tissues, ELISIAs were developed using proteoglycan standards isolated from shark cartilage rich in the 7-D-4 epitope and newborn ovine IVD enriched in the 3-B-3(−) epitope and the purified standards were characterized by CAPAGE, which is a native electrophoretic system that resolves proteoglycans on the basis of charge:mass ratio ( Fig. 9a ). Dissociative CsCl density gradient isopycnic ultracentrifugation fractionated proteoglycan species into high buoyant density (aggrecan, ρ > 1.55 g/mL) and low buoyant density proteoglycans (decorin/biglycan, ρ = 1.3-1.4 g/mL) identified on Immunoblots using the 7-D-4 and 3-B-3 antibodies ( Fig. 9 b-d ).
Figure 9.
Composite agarose–polyacrylamide gel electrophoresis and identification of the 7-D-4 and 3-B-3(−) standards prepared from shark cartilage and newborn ovine intervertebral disc by immunoblotting using MAb 7-D-4 and 3-B-3 (a). The 7-D-4 and 3-B-3(−) standards were isolated by CsCl density gradient ultracentrifugation as shown in (b) for the 7-D-4 standard. Aggrecan was present in the D1 high buoyant density fraction (c). The shark cartilage low buoyant density D5 ultracentrifuge fraction also contained 7-D-4-+ve decorin and biglycan although these were not identified in experimental ovine intervertebral disc (IVD) tissues (c). Identification of the 7-D-4 shark cartilage proteoglycan core protein following chondroitinase ABC digestion. D1 standard (lanes 1 and 2) compared with a newborn ovine articular cartilage proteoglycan sample (lane 3) and the ovine IVD 3-B-3(−) D1D1 proteoglycan standard (lanes 5 and 6). A 30-kDa chondroitin sulfate (CS) sample is also shown in lane 4. The unfractionated newborn cartilage sample resolves into 2 aggrecans (Agg-1, Agg-2) and a decorin/biglycan population (lane 3).
The purified 7-D-4 shark aggrecan and ovine IVD 3-B-3(−) aggrecan standards were used to develop ELISIAs to quantitate relative levels of the 7-D-4 and 3-B-3(−) epitopes in tissue extracts from the 6 × 20 mm lesion site (AF1 zone), the contralateral AF (AF2 zone) and NP from IVDs in which the annular lesion had been induced for 0, 3 and 6 months to induce disc degeneration ( Fig. 10 ). Binding curves were initially established for the proteoglycan standards to optimize coating of the ELISA 96-well microtiter plates ( Fig. 10a ) and standard inhibition curves established for quantitation of unknown samples ( Fig. 10b ). Sulfated GAG levels in the disc zonal extracts and NOC IVDs were also determined ( Fig. 10c and f ). Levels of the CS sulfation motif epitopes 7-D-4 ( Fig. 10d ) and 3-B-3(−) ( Fig. 10e ) were also quantitated by ELISIA compared with the levels in the AF1, AF2, and NP zones of NOC IVDs ( Fig. 10g and h ).
Figure 10.
Measurement of 3-B-3(-) and 7-D-4 chondroitin sulfate (CS) sulfation epitopes by enzyme-linked immunosorbent inhibition assay (ELISIA) using shark cartilage 7-D-4 and 3-B-3(−) proteoglycan standards from newborn ovine intervertebral disc (IVD). ELISA standard binding curves for the proteoglycan standards (a) and ELISIA curves are shown (b). Histograms of the sulfated glycosaminoglycan (GAG) content of annulus fibrosus zone 1 (AF1), AF2, and nucleus pulposus (NP) tissue extracts (c), 7-D-4 (d), 3-B-3(−) content (e) of samples by ELISIA. Six replicates were used for each analysis and mean ± SD data are shown. Lesion data values that were significantly different from nonoperated control (NOC) data are indicated with asterisks (*), *P < 0.001, ** P < 0.0001.
Discussion
The ovine annular lesion model was originally developed to model human disc degeneration23,25 and along with the canine IVD80-83 is the best animal model for such studies providing important insights into IVD pathobiology.20 After conducting numerous studies with the ovine model either in its original format using a 5-mm deep annular lesion23 or in the modified form using a 6 × 20mm lesion51 it became apparent that a number of IVD regenerative features were also apparent.21,22 Spontaneous repair of the outermost annular layers was a consistent feature with type I collagen spanning the original annular surgical incision.84 This material had a disorganized structure compared with the collagen fiber organization in mature annular tissue as demonstrated by its reflectile properties when stained with PicroSirius viewed under polarized light.85 This repair response was confined to the outer annular layers with the inner annular lesion propagating with time into the IVD where it bifurcated, underwent delamellation or developed into concentric or radial tears and also disrupted the normal annular attachments to the cartilaginous endplates.49,50 An influx of cells into the annular lesion site showed some cells expressed α-smooth muscle actin, a myofibroblast marker, these have a contractile phenotype and established roles in wound healing.42 The main structural protein secreted by fibroblasts is collagen which is consistent with the fibrillar overgrowth tissue in the outer annular lesion and the laying down of thickened annular lamellae.49,50 Fibroblasts are important for the production of a new ECM, which supports cell ingrowth and tissue repair. Blood vessels also play an important role supplying oxygen and nutrients to the cells that proliferate in the repair tissue. An ingrowth of blood vessels into the annular lesion site, and expression of FGF-2 by cells in the outer lesion repair site previously observed supported annular repair.42,43 Expression of TGF-β at the lesion site also promoted collagen expression, cellular proliferation and ECM production conducive to repair processes.42 A recent study has shown that HA oligosaccharides upregulated MMP production and activation by AF cells in vitro and anabolic gene expression conducive to the clearance of cell and ECM debris from granulation tissue and annular repair.84 Inflammatory conditions at wound sites leads to HA depolymerization, generating the HA oligosaccharides, which promote the clearance of ECM debris from the defect site by induction of MMPs. These are angiogenic and in combination with TGF-β1, tumor necrosis factor–inducible gene 6 protein (TSG-6) and inter-α-trypsin inhibitor (ITI) can transform fibroblasts to a myo-fibroblastic phenotype conducive to wound repair.86-89 As shown in the present and earlier studies, localized thickening of annular lamellae was prominent in the repair of the outer 5 mm and 6 × 20 mm lesion.22,49,50,84 The 6 × 20 mm lesion is a large defect; its repair is a significant finding. Even so, biomechanical testing of annular repair tissue showed it to be biomechanically inferior to control tissue.29,30,90 Stabilization of the annular lesion site by pedicle plate fixation failed to improve annular repair91 and also demonstrated the unstable nonhealed inner lesion was susceptible to propagation92,93 contributing to its poor healing properties94 and alteration of the multidirectional flexibility of the lumbar spine.95 The mechanical de-stabilisation induced by an outer AF lesion formed the basis of the development of the 6 × 20 mm annular lesion model of experimental disc degeneration used in the present study.51 Internal stresses generated by cycles of compression-relaxation during normal dynamic spinal loading leads to micromotion/instability, which propagates the annular lesions. Whole body vibration induces disc degeneration possibly through physically exacerbating preexisting fatigue microfractures in disc ECM components96 leading to the development of degenerative lesions and also induces inflammatory mediators such as interleukin-1β (IL-1β), multiple MMPs, and generates LBP.97
Chondroid metaplasia was observed in ~20% of the 6 × 20 mm lesion IVDs in the present study but not in the 5-mm lesion samples. This is a benign condition, occurring in connective tissues in response to chronic mechanical stress and may explain why it was not observed with the 5-mm lesion.98 Chondroid metaplasia of paraspinal tissues in the degenerative spine also occurs during remodeling of the erector spinae muscle at the fourth lumbar vertebra99 and is used to describe degenerative histopathology occurring in tendinopathy.100 The term chondroid metaplasia was introduced in the spinal work of Hansen101 on the morphogenesis of aging disc tissues and the early onset of disc degeneration in chondrodystrophoid dog breeds but is also now recognized as a feature of nonchondrodystrophoid canine IVDs.102 Chondroid metaplasia is defined as a proliferation of rounded chondrocyte-like cells surrounded in a hyaline cartilaginous matrix thus is an appropriate descriptive term for the NP outgrowth tissue we observed in the present study. This GAG-rich tissue contained proteoglycans decorated with the 7-D-4 and 3-B-3(−) CS sulfation motifs. These have also been observed in fetal human knee, hip, and elbow joint development where they are synthesized by resident chondroprogenitor cell populations.74,103-106 Chondroid cell colonies have also been observed in the ovine IVD and have been isolated from human IVD tissue as discrete groups of rounded cells surrounded by a basophilic pericellular matrix.107 These cells expressed the 7-D-4 and 3-B-3(−) CS sulfation motifs and the NP stem cell markers CK8 and CK19107 and had a cell surface CD protein profile by flow cytometry consistent with their identity as a progenitor stem cell population.107 An earlier study immunolocalized aggrecan as a component of the basophilic pericellular matrices and ECM surrounding chondroid cell nests in ovine IVDs.108 HA was also present pericellularly around cells within these chondroid cell nests. HA is a common component of the stem cell niche environment.109-111
As found in earlier studies21,22,108 the chondroid cells were significantly larger than the NP cells of the current study. Versican and aggrecan were previously shown to be ECM components of the NP consistent with its identity as a fibrocartilaginous tissue108; however, versican was not detected in the ECM of the chondroid cell colonies demonstrating a clear difference between these tissues. In the present study, we also observed small groups of cells in the inner AF adjacent to the annular lesion atypical of disc cells in control IVD tissues. These appeared similar to cell clusters described in fibrillated articular cartilage in OA and which have been suggested to represent adult stem cells.108 We previously suggested they may arise from chondroid cell nests in the NP, and proposed these were progenitor cells that became activated due to altered micromechanical effects induced by annular lesions in a process resembling the effect of surface fibrillation on cell clustering in OA articular cartilage.73,112 These cell clusters in the inner AF were surrounded in a GAG-rich matrix showing they were metabolically active and were capable of cell division; however, they were incapable of repairing the inner annular lesion. A chondroid tissue mass growing from an extension of the NP into the inner aspects of the annular lesion in ~20% of the lesion IVDs was a prominent feature of the present study. This tissue integrated with the inner annular lamellae distorting the normal arcade structure of this tissue but prevented the bifurcation of the annular lesion into inner aspects of the IVD apparently stabilizing the defect. This chondroid tissue was most prominent 3 months PO, and by 6 months, it had resorbed to a major extent leaving behind annular tissue of a normal appearance. We interpreted this as a reparative response since the lesion did not propagate further into the disc unlike other IVDs where the lesion propagated as far as the contralateral AF in the absence of chondroid metaplasia. Chondroid metaplasia occurred in only ~20% of the lesion affected IVDs, the reasons for this are currently unknown.
Quantitation of the 7-D-4 and 3-B-3(−) epitopes by ELISIA confirmed the histological findings demonstrating an increase in the AF1 zone (but not AF2) accompanied by a depletion in sulphated GAG levels. These CS sulfation motifs are also expressed in OA in fibrillated articular cartilage67; however, the significance of this observation in ovine IVD tissues requires further evaluation.
Footnotes
Acknowledgments and Funding: Profs. Andrew and Christine Dart (Sydney University Veterinary Hospital) and Prof. Christopher B. Little (Institute of Bone and Joint Research, University of Sydney) are thanked for undertaking the sheep surgeries used in this study. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by NHMRC Project Grant 1004032.
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Ethical Approval: All animal welfare and ethics for this work were approved by the University of Sydney Animal Care and Ethics Committee under ethics approval A45/6-2011/3/5544.
Animal Welfare: The present study followed international, national, and/or institutional guidelines for humane animal treatment and complied with relevant legislation.
ORCID iD: James Melrose
https://orcid.org/0000-0001-9237-0524
References
- 1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Andersson GB. Epidemiological features of chronic low-back pain. Lancet. 1999;354(9178):581-5. [DOI] [PubMed] [Google Scholar]
- 3. Smith LJ, Nerurkar NL, Choi KS, Harfe BD, Elliott DM. Degeneration and regeneration of the intervertebral disc: lessons from development. Dis Model Mech. 2011;4(1):31-41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Li J, Han X, Zhang X, Wang S. Spatiotemporal evolution of global population ageing from 1960 to 2017. BMC Public Health. 2019;19(1):127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Luoma K, Riihimaki H, Luukkonen R, Raininko R, Viikari-Juntura E, Lamminen A. Low back pain in relation to lumbar disc degeneration. Spine (Phila Pa 1976). 2000;25(4):487-92. [DOI] [PubMed] [Google Scholar]
- 6. Strine TW, Hootman JM. US national prevalence and correlates of low back and neck pain among adults. Arthritis Rheum. 2007;57(4):656-65. [DOI] [PubMed] [Google Scholar]
- 7. Hoy D, Brooks P, Blyth F, Buchbinder R. The epidemiology of low back pain. Best Pract Res Clin Rheumatol. 2010;24(6):769-81. [DOI] [PubMed] [Google Scholar]
- 8. Maniadakis N, Gray A. The economic burden of back pain in the UK. Pain. 2000;84(1):95-103. [DOI] [PubMed] [Google Scholar]
- 9. Walker BF, Muller R, Grant WD. Low back pain in Australian adults: the economic burden. Asia Pac J Public Health. 2003;15(2):79-87. [DOI] [PubMed] [Google Scholar]
- 10. Fritz JM, Cleland JA, Speckman M, Brennan GP, Hunter SJ. Physical therapy for acute low back pain: associations with subsequent healthcare costs. Spine (Phila Pa 1976). 2008;33(16):1800-5. [DOI] [PubMed] [Google Scholar]
- 11. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743-800. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Dieleman JL, Baral R, Birger M, Bui AL, Bulchis A, Chapin A, et al. US spending on personal health care and public health, 1996-2013. JAMA. 2016;316(24):2627-46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Ehrlich GE, Khaltaev NG; World Health Organization; Chronic Respiratory Diseases and Arthritis Team. Low back pain initiative. Geneva: World Health Organization; 1999. [Google Scholar]
- 14. Briggs AM, Buchbinder R. Back pain: a national health priority area in Australia? Med J Aust. 2009;190(9):499-502. [DOI] [PubMed] [Google Scholar]
- 15. Sanger N, Bhatt M, Singhal N, Ramsden K, Baptist-Mohseni N, Panesar B, et al. Adverse outcomes associated with prescription opioids for acute low back pain: a systematic review and meta-analysis. Pain Physician. 2019;22(2):119-38. [PubMed] [Google Scholar]
- 16. Maroudas A, Stockwell RA, Nachemson A, Urban J. Factors involved in the nutrition of the human lumbar intervertebral disc: cellularity and diffusion of glucose in vitro. J Anat. 1975;120(Pt 1):113-30. [PMC free article] [PubMed] [Google Scholar]
- 17. Urban JP, Smith S, Fairbank JC. Nutrition of the intervertebral disc. Spine (Phila Pa 1976). 2004;29(23):2700-9. [DOI] [PubMed] [Google Scholar]
- 18. Smith LJ, Silverman L, Sakai D, Le Maitre CL, Mauck RL, Malhotra NR, et al. Advancing cell therapies for intervertebral disc regeneration from the lab to the clinic: recommendations of the ORS spine section. JOR Spine. 2018;1(4):e1036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Tong W, Lu Z, Qin L, Mauck RL, Smith HE, Smith LJ, et al. Cell therapy for the degenerating intervertebral disc. Transl Res. 2017;181:49-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Alini M, Eisenstein SM, Ito K, Little C, Kettler AA, Masuda K, et al. Are animal models useful for studying human disc disorders/degeneration? Eur Spine J. 2008;17(1):2-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Shu CC, Smith MM, Smith SM, Dart AJ, Little CB, Melrose J. A histopathological scheme for the quantitative scoring of intervertebral disc degeneration and the therapeutic utility of adult mesenchymal stem cells for intervertebral disc regeneration. Int J Mol Sci. 2017;18(5):E1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Shu C, Dart A, Bell R, Dart C, Clarke E, Smith MM, et al. Efficacy of administered mesenchymal stem cells in the initiation and co-ordination of repair processes by resident disc cells in an ovine (Ovis aries) large destabilising lesion model of experimental disc degeneration. JOR Spine. 2018;1(4):e1037. doi: 10.1002/jsp2.1037 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Osti OL, Vernon-Roberts B, Fraser RD. 1990 Volvo Award in experimental studies. Anulus tears and intervertebral disc degeneration. An experimental study using an animal model. Spine (Phila Pa1976). 1990;15(8):762-7. [DOI] [PubMed] [Google Scholar]
- 24. Osti OL, Vernon-Roberts B, Moore R, Fraser RD. Annular tears and disc degeneration in the lumbar spine. A post-mortem study of 135 discs. J Bone Joint Surg Br. 1992;74(5):678-82. [DOI] [PubMed] [Google Scholar]
- 25. Melrose J, Ghosh P, Taylor TK, Hall A, Osti OL, Vernon-Roberts B, et al. A longitudinal study of the matrix changes induced in the intervertebral disc by surgical damage to the annulus fibrosus. J Orthop Res. 1992;10(5):665-76. [DOI] [PubMed] [Google Scholar]
- 26. Melrose J, Ghosh P, Taylor TK, Latham J, Moore R. Topographical variation in the catabolism of aggrecan in an ovine annular lesion model of experimental disc degeneration. J Spinal Disord. 1997;10(1):55-67. [PubMed] [Google Scholar]
- 27. Melrose J, Ghosh P, Taylor TK, Vernon-Roberts B, Latham J, Moore R. Elevated synthesis of biglycan and decorin in an ovine annular lesion model of experimental disc degeneration. Eur Spine J. 1997;6(6):376-84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Easley NE, Wang M, McGrady LM, Toth JM. Biomechanical and radiographic evaluation of an ovine model for the human lumbar spine. Proc Inst Mech Eng H. 2008;222(6):915-22. [DOI] [PubMed] [Google Scholar]
- 29. Little JP, Pearcy MJ, Tevelen G, Evans JH, Pettet G, Adam CJ. The mechanical response of the ovine lumbar anulus fibrosus to uniaxial, biaxial and shear loads. J Mech Behav Biomed Mater. 2010;3(2):146-57. [DOI] [PubMed] [Google Scholar]
- 30. Newell N, Little JP, Christou A, Adams MA, Adam CJ, Masouros SD. Biomechanics of the human intervertebral disc: a review of testing techniques and results. J Mech Behav Biomed Mater. 2017;69:420-34. [DOI] [PubMed] [Google Scholar]
- 31. Schollum ML, Robertson PA, Broom ND. ISSLS prize winner: microstructure and mechanical disruption of the lumbar disc annulus: part I: a microscopic investigation of the translamellar bridging network. Spine (Phila Pa 1976). 2008;33(25):2702-10. [DOI] [PubMed] [Google Scholar]
- 32. Thompson RE, Pearcy MJ, Barker TM. The mechanical effects of intervertebral disc lesions. Clin Biomech (Bristol, Avon). 2004;19(5):448-55. [DOI] [PubMed] [Google Scholar]
- 33. Melrose J, Roughley PJ. Proteoglycans of the intervertebral disc. In: Shapiro IM, Risbud MV, editors. The intervertebral disc. Molecular and structural studies of the disc in health and disease. Vienna, Austria: Springer-Verlag; 2014. p. 53-78. [Google Scholar]
- 34. Melrose J, Smith SM, Fuller ES, Young AA, Roughley PJ, Dart A, et al. Biglycan and fibromodulin fragmentation correlates with temporal and spatial annular remodelling in experimentally injured ovine intervertebral discs. Eur Spine J. 2007;16(12):2193-205. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Ameye L, Aria D, Jepsen K, Oldberg A, Xu T, Young MF. Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J. 2002;16(7):673-80. [DOI] [PubMed] [Google Scholar]
- 36. Chen L, Liao J, Klineberg E, Leung VY, Huang S. Small leucine-rich proteoglycans (SLRPs): characteristics and function in the intervertebral disc. J Tissue Eng Regen Med. 2017;11(3):602-8. [DOI] [PubMed] [Google Scholar]
- 37. Hayes AJ, Isaacs MD, Hughes C, Caterson B, Ralphs JR. Collagen fibrillogenesis in the development of the annulus fibrosus of the intervertebral disc. Eur Cell Mater. 2011;22:226-41. [DOI] [PubMed] [Google Scholar]
- 38. Iozzo RV. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol. 1997;32(2):141-74. [DOI] [PubMed] [Google Scholar]
- 39. Robinson KA, Sun M, Barnum CE, Weiss SN, Huegel J, Shetye SS, et al. Decorin and biglycan are necessary for maintaining collagen fibril structure, fiber realignment, and mechanical properties of mature tendons. Matrix Biol. 2017;64:81-93. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Schaefer L, Iozzo RV. Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem. 2008;283(31):21305-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Hultgårdh-Nilsson A, Borén J, Chakravarti S. The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis. J Intern Med. 2015;278(5):447-61. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Melrose J, Smith S, Little CB, Kitson J, Hwa SY, Ghosh P. Spatial and temporal localization of transforming growth factor-beta, fibroblast growth factor-2, and osteonectin, and identification of cells expressing alpha-smooth muscle actin in the injured anulus fibrosus: implications for extracellular matrix repair. Spine (Phila Pa 1976). 2002;27(16):1756-64. [DOI] [PubMed] [Google Scholar]
- 43. Melrose J, Roberts S, Smith S, Menage J, Ghosh P. Increased nerve and blood vessel ingrowth associated with proteoglycan depletion in an ovine anular lesion model of experimental disc degeneration. Spine (Phila Pa 1976). 2002;27(12):1278-85. [DOI] [PubMed] [Google Scholar]
- 44. Fagan A, Moore R, Roberts BV, Blumbergs P, Fraser R. ISSLS prize winner: the innervation of the intervertebral disc: a quantitative analysis. Spine (Phila Pa 1976). 2003;28(23):2570-6. [DOI] [PubMed] [Google Scholar]
- 45. Freemont AJ, Peacock TE, Goupille P, Hoyland JA, O’Brien J, Jayson MI. Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet. 1997;350(9072):178-81. [DOI] [PubMed] [Google Scholar]
- 46. Moore RJ, Osti OL, Vernon-Roberts B, Fraser RD. Changes in endplate vascularity after an outer anulus tear in the sheep. Spine (Phila Pa 1976). 1992;17(8):874-8. [DOI] [PubMed] [Google Scholar]
- 47. Moore RJ, Vernon-Roberts B, Osti OL, Fraser RD. Remodeling of vertebral bone after outer anular injury in sheep. Spine (Phila Pa 1976). 1996;21(8):936-40. [DOI] [PubMed] [Google Scholar]
- 48. Moore RJ, Crotti TN, Osti OL, Fraser RD, Vernon-Roberts B. Osteoarthrosis of the facet joints resulting from anular rim lesions in sheep lumbar discs. Spine (Phila Pa 1976). 1999;24(6):519-25. [DOI] [PubMed] [Google Scholar]
- 49. Melrose J, Smith SM, Little CB, Moore RJ, Vernon-Roberts B, Fraser RD. Recent advances in annular pathobiology provide insights into rim-lesion mediated intervertebral disc degeneration and potential new approaches to annular repair strategies. Eur Spine J. 2008;17(9):1131-48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Schollum ML, Appleyard RC, Little CB, Melrose J. A detailed microscopic examination of alterations in normal anular structure induced by mechanical destabilization in an ovine model of disc degeneration. Spine (Phila Pa 1976). 2010;35(22):1965-73. [DOI] [PubMed] [Google Scholar]
- 51. Melrose J, Shu C, Young C, Ho R, Smith MM, Young AA, et al. Mechanical destabilization induced by controlled annular incision of the intervertebral disc dysregulates metalloproteinase expression and induces disc degeneration. Spine (Phila Pa 1976). 2012;37(1):18-25. [DOI] [PubMed] [Google Scholar]
- 52. Colloca CJ, Gunzburg R, Freeman BJ, Szpalski M, Afifi M, Moore RJ. Biomechanical quantification of pathologic manipulable spinal lesions: an in vivo ovine model of spondylolysis and intervertebral disc degeneration. J Manipulative Physiol Ther. 2012;35(5):354-66. [DOI] [PubMed] [Google Scholar]
- 53. Colloca CJ, Keller TS, Harrison DE, Moore RJ, Gunzburg R, Harrison DD. Spinal manipulation force and duration affect vertebral movement and neuromuscular responses. Clin Biomech (Bristol, Avon). 2006;21(3):254-62. [DOI] [PubMed] [Google Scholar]
- 54. Colloca CJ, Keller TS, Moore RJ, Gunzburg R, Harrison DE. Intervertebral disc degeneration reduces vertebral motion responses. Spine (Phila Pa 1976). 2007;32(19):E544-E550. [DOI] [PubMed] [Google Scholar]
- 55. Colloca CJ, Keller TS, Moore RJ, Gunzburg R, Harrison DE. Effects of disc degeneration on neurophysiological responses during dorsoventral mechanical excitation of the ovine lumbar spine. J Electromyogr Kinesiol. 2008;18(5):829-37. [DOI] [PubMed] [Google Scholar]
- 56. Hodges PW, James G, Blomster L, Hall L, Schmid A, Shu C, et al. Multifidus muscle changes after back injury are characterized by structural remodeling of muscle, adipose and connective tissue, but not muscle atrophy: molecular and morphological evidence. Spine (Phila Pa 1976). 2015;40(14):1057-71. [DOI] [PubMed] [Google Scholar]
- 57. Hodges PW, James G, Blomster L, Hall L, Schmid AB, Shu C, et al. Can proinflammatory cytokine gene expression explain multifidus muscle fiber changes after an intervertebral disc lesion? Spine (Phila Pa 1976). 2014;39(13):1010-7. [DOI] [PubMed] [Google Scholar]
- 58. James G, Blomster L, Hall L, Schmid AB, Shu CC, Little CB, et al. Mesenchymal stem cell treatment of intervertebral disc lesion prevents fatty infiltration and fibrosis of the multifidus muscle, but not cytokine and muscle fiber changes. Spine (Phila Pa 1976). 2016;41(15):1208-17. [DOI] [PubMed] [Google Scholar]
- 59. James G, Sluka KA, Blomster L, Hall L, Schmid AB, Shu CC, et al. Macrophage polarization contributes to local inflammation and structural change in the multifidus muscle after intervertebral disc injury. Eur Spine J. 2018;27(8):1744-56. [DOI] [PubMed] [Google Scholar]
- 60. Caterson B, Mahmoodian F, Sorrell JM, Hardingham TE, Bayliss MT, Carney SL, et al. Modulation of native chondroitin sulphate structure in tissue development and in disease. J Cell Sci. 1990;97(Pt 3):411-7. [DOI] [PubMed] [Google Scholar]
- 61. Sorrell JM, Lintala AM, Mahmoodian F, Caterson B. Epitope-specific changes in chondroitin sulfate/dermatan sulfate proteoglycans as markers in the lymphopoietic and granulopoietic compartments of developing bursae of Fabricius. J Immunol. 1988;140(12):4263-70. [PubMed] [Google Scholar]
- 62. Sorrell JM, Mahmoodian F, Schafer IA, Davis B, Caterson B. Identification of monoclonal antibodies that recognize novel epitopes in native chondroitin/dermatan sulfate glycosaminoglycan chains: their use in mapping functionally distinct domains of human skin. J Histochem Cytochem. 1990;38(3):393-402. [DOI] [PubMed] [Google Scholar]
- 63. Sorreli JM, Carrino DA, Caplan AI. Regulated expression of chondroitin sulfates at sites of epithelial-mesenchymal interaction: spatio-temporal patterning identified with anti-chondroitin sulfate monoclonal antibodies. Int J Dev Neurosci. 1996;14(3):233-48. [DOI] [PubMed] [Google Scholar]
- 64. Adams ME, Grant MD, Ho A. Cartilage proteoglycan changes in experimental canine osteoarthritis. J Rheumatol. 1987;14(Spec No):107-9. [PubMed] [Google Scholar]
- 65. Carney SL, Billingham ME, Caterson B, Ratcliffe A, Bayliss MT, Hardingham TE, et al. Changes in proteoglycan turnover in experimental canine osteoarthritic cartilage. Matrix. 1992;12(2):137-47. [DOI] [PubMed] [Google Scholar]
- 66. Slater RR, Jr, Bayliss MT, Lachiewicz PF, Visco DM, Caterson B. Monoclonal antibodies that detect biochemical markers of arthritis in humans. Arthritis Rheum. 1995;38(5):655-9. [DOI] [PubMed] [Google Scholar]
- 67. Visco DM, Johnstone B, Hill MA, Jolly GA, Caterson B. Immunohistochemical analysis of 3-B-(−) and 7-D-4 epitope expression in canine osteoarthritis. Arthritis Rheum. 1993;36(12):1718-25. [DOI] [PubMed] [Google Scholar]
- 68. Caterson B, Calabro T, Hampton A. Monoclonal antibodies as probes for elucidating proteoglycan structure and function. In: Wright T, Mecham R, editors. Biology of proteoglycans. New York: Academic Press; 1987. p. 1-26. [Google Scholar]
- 69. Caterson B, Christner JE, Baker JR, Couchman JR. Production and characterization of monoclonal antibodies directed against connective tissue proteoglycans. Fed Proc. 1985;44(2):386-93. [PubMed] [Google Scholar]
- 70. Couchman JR, Caterson B, Christner JE, Baker JR. Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues. Nature. 1984;307(5952):650-2. [DOI] [PubMed] [Google Scholar]
- 71. Sorrell JM, Carrino DA, Caplan AI. Structural domains in chondroitin sulfate identified by anti-chondroitin sulfate monoclonal antibodies. Immunosequencing of chondroitin sulfates. Matrix. 1993;13(5):351-61. [DOI] [PubMed] [Google Scholar]
- 72. Khan IM, Williams R, Archer CW. One flew over the progenitor’s nest: migratory cells find a home in osteoarthritic cartilage. Cell Stem Cell. 2009;4(4):282-4. [DOI] [PubMed] [Google Scholar]
- 73. Tesche F, Miosge N. New aspects of the pathogenesis of osteoarthritis: the role of fibroblast-like chondrocytes in late stages of the disease. Histol Histopathol. 2005;20(1):329-37. [DOI] [PubMed] [Google Scholar]
- 74. Melrose J, Isaacs MD, Smith SM, Hughes CE, Little CB, Caterson B, et al. Chondroitin sulphate and heparan sulphate sulphation motifs and their proteoglycans are involved in articular cartilage formation during human foetal knee joint development. Histochem Cell Biol. 2012;138(3):461-75. [DOI] [PubMed] [Google Scholar]
- 75. Christner JE, Caterson B, Baker JR. Immunological determinants of proteoglycans. Antibodies against the unsaturated oligosaccharide products of chondroitinase ABC-digested cartilage proteoglycans. J Biol Chem. 1980;255(15):7102-5. [PubMed] [Google Scholar]
- 76. Sorrell JM, Mahmoodian F, Caterson B. Immunochemical and biochemical comparisons between embryonic chick bone marrow and epiphyseal cartilage chondroitin/dermatan sulphate proteoglycans. J Cell Sci. 1988;91(Pt 1):81-90. [DOI] [PubMed] [Google Scholar]
- 77. Melrose J, Little CB, Ghosh P. Detection of aggregatable proteoglycan populations by affinity blotting using biotinylated hyaluronan. Anal Biochem. 1998;256(2):149-57. [DOI] [PubMed] [Google Scholar]
- 78. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta. 1986;83(2):173-7. [DOI] [PubMed] [Google Scholar]
- 79. Ratcliffe A, Shurety W, Caterson B. The quantitation of a native chondroitin sulfate epitope in synovial fluid lavages and articular cartilage from canine experimental osteoarthritis and disuse atrophy. Arthritis Rheum. 1993;36(4):543-51. [DOI] [PubMed] [Google Scholar]
- 80. Bergknut N, Grinwis G, Pickee E, Auriemma E, Lagerstedt AS, Hagman R, et al. Reliability of macroscopic grading of intervertebral disk degeneration in dogs by use of the Thompson system and comparison with low-field magnetic resonance imaging findings. Am J Vet Res. 2011;72(7):899-904. [DOI] [PubMed] [Google Scholar]
- 81. Bergknut N, Meij BP, Hagman R, de Nies KS, Rutges JP, Smolders LA, et al. Intervertebral disc disease in dogs—part 1: a new histological grading scheme for classification of intervertebral disc degeneration in dogs. Vet J. 2013;195(2):156-63. [DOI] [PubMed] [Google Scholar]
- 82. Bergknut N, Rutges JP, Kranenburg HJ, Smolders LA, Hagman R, Smidt HJ, et al. The dog as an animal model for intervertebral disc degeneration? Spine (Phila Pa 1976). 2012;37(5):351-8. [DOI] [PubMed] [Google Scholar]
- 83. Bergknut N, Smolders LA, Grinwis GC, Hagman R, Lagerstedt AS, Hazewinkel HA, et al. Intervertebral disc degeneration in the dog. Part 1: anatomy and physiology of the intervertebral disc and characteristics of intervertebral disc degeneration. Vet J. 2013;195(3):282-91. [DOI] [PubMed] [Google Scholar]
- 84. Fuller ES, Shu C, Smith MM, Little CB, Melrose J. Hyaluronan oligosaccharides stimulate matrix metalloproteinase and anabolic gene expression in vitro by intervertebral disc cells and annular repair in vivo. J Tissue Eng Regen Med. 2018;12(1):e216-e226. [DOI] [PubMed] [Google Scholar]
- 85. Schollum ML, Robertson PA, Broom ND. A microstructural investigation of intervertebral disc lamellar connectivity: detailed analysis of the translamellar bridges. J Anat. 2009;214(6):805-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. David-Raoudi M, Tranchepain F, Deschrevel B, Vincent JC, Bogdanowicz P, Boumediene K, et al. Differential effects of hyaluronan and its fragments on fibroblasts: relation to wound healing. Wound Repair Regen. 2008;16(2):274-87. [DOI] [PubMed] [Google Scholar]
- 87. Meran S, Thomas DW, Stephens P, Enoch S, Martin J, Steadman R, et al. Hyaluronan facilitates transforming growth factor-β1–mediated fibroblast proliferation. J Biol Chem. 2008;283(10):6530-45. [DOI] [PubMed] [Google Scholar]
- 88. Midgley AC, Rogers M, Hallett MB, Clayton A, Bowen T, Phillips AO, et al. Transforming growth factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts. J Biol Chem. 2013;288(21):14824-38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89. Webber J, Meran S, Steadman R, Phillips A. Hyaluronan orchestrates transforming growth factor-beta1-dependent maintenance of myofibroblast phenotype. J Biol Chem. 2009;284(14):9083-92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90. Detiger SE, Hoogendoorn RJ, van der Veen AJ, van Royen BJ, Helder MN, Koenderink GH, et al. Biomechanical and rheological characterization of mild intervertebral disc degeneration in a large animal model. J Orthop Res. 2013;31(5):703-9. [DOI] [PubMed] [Google Scholar]
- 91. Moore RJ, Latham JM, Vernon-Roberts B, Fraser RD. Does plate fixation prevent disc degeneration after a lateral anulus tear? Spine (Phila Pa 1976). 1994;19(24):2787-90. [DOI] [PubMed] [Google Scholar]
- 92. Reutlinger C, Bürki A, Brandejsky V, Ebert L, Büchler P. Specimen specific parameter identification of ovine lumbar intervertebral discs: on the influence of fibre-matrix and fibre-fibre shear interactions. J Mech Behav Biomed Mater. 2014;30:279-89. [DOI] [PubMed] [Google Scholar]
- 93. Stewart DM, Monaco LA, Gregory DE. The aging disc: using an ovine model to examine age-related differences in the biomechanical properties of the intralamellar matrix of single lamellae. Eur Spine J. 2017;26(1):259-266. [DOI] [PubMed] [Google Scholar]
- 94. Schnake KJ, Putzier M, Haas NP, Kandziora F. Mechanical concepts for disc regeneration. Eur Spine J. 2006;15(Suppl 3):S354-S360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95. Mimura M, Panjabi MM, Oxland TR, Crisco JJ, Yamamoto I, Vasavada A. Disc degeneration affects the multidirectional flexibility of the lumbar spine. Spine (Phila Pa 1976). 1994;19(12):1371-80. [DOI] [PubMed] [Google Scholar]
- 96. Guo LX, Fan W. The effect of single-level disc degeneration on dynamic response of the whole lumbar spine to vertical vibration. World Neurosurg. 2017;105:510-8. [DOI] [PubMed] [Google Scholar]
- 97. McCann MR, Veras MA, Yeung C, Lalli G, Patel P, Leitch KM, et al. Whole-body vibration of mice induces progressive degeneration of intervertebral discs associated with increased expression of Il-1β and multiple matrix degrading enzymes. Osteoarthritis Cartilage. 2017;25(5):779-89. [DOI] [PubMed] [Google Scholar]
- 98. Shon W, Folpe AL. Myxochondroid metaplasia of the plantar foot: a distinctive pseudoneoplastic lesion resembling nuchal fibrocartilaginous pseudotumor and the equine digital cushion. Mod Pathol. 2013;26(12):1561-7. [DOI] [PubMed] [Google Scholar]
- 99. Stevens S, Agten A, Wisanto E, Monaco M, Verbrugghe J, Timmermans A, et al. Chondroid metaplasia of paraspinal connective tissue in the degenerative spine. Anat Cell Biol. 2019;52(2):204-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100. Khan KM, Cook JL, Bonar F, Harcourt P, Astrom M. Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med. 1999;27(6):393-408. [DOI] [PubMed] [Google Scholar]
- 101. Hansen HJ. A pathologic-anatomical study on disc degeneration in dog, with special reference to the so-called enchondrosis intervertebralis. Acta Orthop Scand Suppl. 1952;11:1-117. [DOI] [PubMed] [Google Scholar]
- 102. Hansen T, Smolders LA, Tryfonidou MA, Meij BP, Vernooij JCM, Bergknut N, et al. The myth of fibroid degeneration in the canine intervertebral disc: a histopathological comparison of intervertebral disc degeneration in chondrodystrophic and nonchondrodystrophic dogs. Vet Pathol. 2017;54(6):945-52. [DOI] [PubMed] [Google Scholar]
- 103. Caterson B. Fell-Muir lecture: chondroitin sulphate glycosaminoglycans: fun for some and confusion for others. Int J Exp Pathol. 2012;93(1):1-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104. Hayes AJ, Hughes CE, Ralphs JR, Caterson B. Chondroitin sulphate sulphation motif expression in the ontogeny of the intervertebral disc. Eur Cell Mater. 2011;21:1-14. [PubMed] [Google Scholar]
- 105. Hayes AJ, Hughes CE, Smith SM, Caterson B, Little CB, Melrose J. The CS sulfation motifs 4C3, 7D4, 3B3[−]; and perlecan identify stem cell populations and their niches, activated progenitor cells and transitional areas of tissue development in the fetal human elbow. Stem Cells Dev. 2016;25(11):836-47. [DOI] [PubMed] [Google Scholar]
- 106. Hayes AJ, Smith SM, Caterson B, Melrose J. Concise review: stem/progenitor cell proteoglycans decorated with 7-D-4, 4-C-3, and 3-B-3(−) chondroitin sulfate motifs are morphogenetic markers of tissue development. Stem Cells. 2018;36(10):1475-86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107. Turner S, Balain B, Caterson B, Morgan C, Roberts S. Viability, growth kinetics and stem cell markers of single and clustered cells in human intervertebral discs: implications for regenerative therapies. Eur Spine J. 2014;23(11):2462-72. [DOI] [PubMed] [Google Scholar]
- 108. Brown S, Matta A, Erwin M, Roberts S, Gruber HE, Hanley EN, Jr, et al. Cell clusters are indicative of stem cell activity in the degenerate intervertebral disc: can their properties be manipulated to improve intrinsic repair of the disc? Stem Cells Dev. 2018;27(3):147-65. [DOI] [PubMed] [Google Scholar]
- 109. Gesteira T, Sun M, Coulson-Thomas YM, Yamaguchi Y, Yeh LK, Hascall V, et al. Hyaluronan rich microenvironment in the limbal stem cell niche regulates limbal stem cell differentiation. Invest Ophthalmol Vis Sci. 2017;58(11):4407-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110. Nava M, Raimondi MT, Credi C, De Marco C, Turri S, Cerullo G, et al. Interactions between structural and chemical biomimetism in synthetic stem cell niches. Biomed Mater. 2015;10(1):015012. [DOI] [PubMed] [Google Scholar]
- 111. Simpson R, Hong X, Wong MM, Karamariti E, Bhaloo SI, Warren D, et al. Hyaluronan is crucial for stem cell differentiation into smooth muscle lineage. Stem Cells. 2016;34(5):1225-38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112. Tesche F, Miosge N. Perlecan in late stages of osteoarthritis of the human knee joint. Osteoarthritis Cartilage. 2004;12:852-62. [DOI] [PubMed] [Google Scholar]






